|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Wake Forest University School of Medicine
* To whom correspondence should be addressed. E-mail: atrask{at}wfubmc.edu.
Identification of angiotensin-(1-12) as an intermediate precursor derived directly from angiotensinogen led us to explore whether the heart has the capacity to process angiotensin-(1-12) into the biologically-active angiotensin peptides. The generation of angiotensin I, angiotensin II, and angiotensin-(1-7) from exogenous angiotensin-(1-12) was evaluated in the effluent of isolated perfused hearts mounted on a Langendorff apparatus in three normotensive and two hypertensive strains - the Sprague-Dawley, Lewis, congenic mRen2.Lewis, Wistar-Kyoto, and Spontaneously Hypertensive rats. Hearts were perfused with Krebs solution for 60 minutes before and after the addition of angiotensin-(1-12) (10 nmol/L). Angiotensin-(1-12) caused the rapid appearance of both angiotensin I and angiotensin II in the perfusate that peaked between 30 and 60 minutes of recirculation. Production of angiotensin-(1-7) from exogenous angiotensin-(1-12) rose steadily over the course of the 60-minute experiment. These data directly demonstrate that angiotensin-(1-12) is a substrate for the formation of angiotensin peptides in cardiac tissue. This finding further suggests that this angiotensinogen-derived product is a previously unrecognized important precursor peptide to the renin-angiotensin system cascade.
This article has been cited by other articles:
![]() |
E. Lazartigues A map and new directions for the (pro)renin receptor in the brain: focus on "A role of the (pro)renin receptor in neuronal cell differentiation" Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R248 - R249. [Full Text] [PDF] |
||||
![]() |
C. B. Herath, J. S. Lubel, Z. Jia, E. Velkoska, D. Casley, L. Brown, C. Tikellis, L. M. Burrell, and P. W. Angus Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2 Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G98 - G106. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Isa, M. A. Garcia-Espinosa, A. C. Arnold, N. T. Pirro, E. N. Tommasi, D. Ganten, M. C. Chappell, C. M. Ferrario, and D. I. Diz Chronic immunoneutralization of brain angiotensin-(1-12) lowers blood pressure in transgenic (mRen2)27 hypertensive rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2009; 297(1): R111 - R115. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. M. Cummins A new addition to the renin-angiotensin peptide family: proAngiotensin-12 (PA12) Cardiovasc Res, April 1, 2009; 82(1): 7 - 8. [Full Text] [PDF] |
||||
![]() |
C. M. Ferrario, J. Varagic, J. Habibi, S. Nagata, J. Kato, M. C. Chappell, A. J. Trask, K. Kitamura, A. Whaley-Connell, and J. R. Sowers Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1184 - H1192. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. C.G. Prosser, M. E. Forster, A. M. Richards, and C. J. Pemberton Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics Cardiovasc Res, April 1, 2009; 82(1): 40 - 50. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. I. Diz Future Directions in Cardiovascular Pharmacology: Examples from the Renin-Angiotensin System Mol. Interv., October 1, 2008; 8(5): 222 - 225. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |
| Visit Other APS Journals Online |